ZOCAGLUSAGENE NUZAPARVOVEC

UNII:	FDB4GQ8A3Y
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	ZOCAGLUSAGENE NUZAPARVOVEC
GSRS Full Record:	FDB4GQ8A3Y i

2601264-52-0
AT-845
AT845
DNA (recombinant adeno-associated virus vector AT845 mouse muscle-type creatine kinase enhancer plus mouse muscle-type creatine kinase promoter plus human lysosomal α-glucosidase precursor codon-optimized transgene plus simian virus 40 polyadenylation signal plus adeno-associated virus 2 inverted terminal repeat flanks-specifying)
Recombinant, non-replicating adeno-associated virus serotype 8 (rAAV8) vector encoding codon-optimized human acid alpha-glucosidase (GAA), also called lysosomal α-glucosidase or acid maltase, under control of a mouse muscle creatine kinase (MCK) enhancer/promoter followed by a simian virus 40 (SV40) intron, terminated by the SV40 late polyadenylation sequence, and flanked by AAV2 inverted terminal repeats (ITRs)
ZOCAGLUSAGENE NUZAPARVOVEC [USAN]
Zocaglusagene Nuzaparvovec
zocaglusagene nuzaparvovec [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZOCAGLUSAGENE NUZAPARVOVEC

Synonyms and Mappings

Resources